4
Changes in Ownership
Indaptus Therapeutics, Inc. Filed Acc 0001493152-26-003293
Director acquired 25,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ben-Tzvi Avraham Director | 2026-01-20 | Grant or award | +25,000 | 25,100 | D | ||
| Derivatives | |||||||
| Ben-Tzvi Avraham Director | 2025-12-23 | Grant or award · Option to Buy Common Stock | +25,000 | 25,000 | D | ||
Loading xslF345X05/ownership.xml…